Infectious Diseases Archive — Page 2 of 13
-
December 15, 2025
Antibody research may lead to broadly protective flu vaccine
These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu. -
December 11, 2025
Experts call for better adherence to guidelines for antiviral prescribing for children at higher risk of severe influenza
Researchers found a substantial gap between recommendations and real-world treatment practices in pediatric EDs (emergency departments) across the country. -
December 1, 2025
Timothy Sterling receives $5.7 million to study tuberculosis transmission
Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission. -
November 17, 2025
VUMC’s Robert Carnahan named a 2025 Master Innovator
He is a translational scientist and antibody engineer who specializes in rapid therapeutic development for emerging infectious diseases. -
November 11, 2025
Drug resistant infections are on the rise: Experts emphasize education, awareness
Teams at VUMC and Monroe Carell are focused on reaching more clinicians, patients and families through the Vanderbilt Antimicrobial Stewardship Program. -
November 5, 2025
Keipp Talbot wins Anthony Fauci Courage in Leadership Award
Bestowed by the Infectious Diseases Society of America, the award "celebrates individuals who inspire and encourage others to make a difference." -
November 4, 2025
AI can speed antibody design to thwart novel viruses: study
While the study focused on development of antibody therapeutics against existing and emerging viral threats, the implications of the research are much broader.